M&A Deal Summary |
|
|---|---|
| Date | 2021-09-16 |
| Target | Avitide |
| Sector | Life Science |
| Buyer(s) | Repligen |
| Sellers(s) | Polaris Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 150M USD |
| Advisor(s) | EC M&A (Financial) Morgan Lewis (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1981 |
| Sector | Life Science |
| Employees | 1,123 |
| Revenue | 802M USD (2022) |
Repligen is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Repligen was founded in 1981 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 10 |
| Sector (Life Science) | 2 of 2 |
| Type (Add-on Acquisition) | 9 of 10 |
| State (New Hampshire) | 1 of 1 |
| Country (United States) | 5 of 5 |
| Year (2021) | 2 of 2 |
| Size (of disclosed) | 4 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-22 |
Polymem
Castanet Tolosan, France Polymem engages in the development and manufacture of hollow fiber membranes, membrane modules, and systems. These products are used in water treatment, solid/liquid separation, gas separation, liquid/gas transfer, and bioprocessing applications. Polymem was founded in 1997 and is based in Castanet Tolosan, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-09-26 |
Metenova
Mölndal, Sweden Metenova is a provider of critical products and solutions for the production of aseptic and sterile pharmaceuticals. Metenova operates globally with leading companies within pharmaceutical and biotech industries mainly through a distributor network. Metenova was established in 2009 and is based in Mölndal, Sweden. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 5.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 27 of 30 |
| Sector (Life Science) | 4 of 6 |
| Type (Add-on Acquisition) | 10 of 13 |
| State (New Hampshire) | 1 of 1 |
| Country (United States) | 25 of 28 |
| Year (2021) | 3 of 4 |
| Size (of disclosed) | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-09 |
Muna Therapeutics
Copenhagen , Denmark Muna Therapeutics is a neurology focused biotech company working on developing novel therapeutics for neurodegenerative diseases. Muna Therapeutics was founded in 2020 and is based in Copenhagen, Denmark. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-21 |
Nomad Health
New York, New York, United States Nomad Health is a healthcare staffing platform designed to connect nurses to rewarding opportunities and address the healthcare staffing shortage. Nomad eliminates the chaotic and inelegant healthcare staffing system of yesterday and replaces it with a simple, modern platform that just works. Nomad Health was founded in 2015 and is based in New York city. |
Buy | - |
